Congenital Cardiac Anesthesia Society
A Section of the the Society for Pediatric Anesthesia

Congenital Cardiac Anesthesia Society

  • Member Login
  • Forgot Password?
  • Join
  • Home
  • About
    • Mission Statement
    • Bylaws
    • Board of Directors
    • History
    • Past Presidents
    • Charter Members
    • CCAS Lifetime Achievement Award
    • Mailing List Rental
    • Contact Us
  • Partners
    • SPA
    • SPPM
    • PALC
    • PCICS
    • AmSECT
    • SMACT
    • CHA
    • CCAN
  • Committees
    • CCAS Committees
      • Pediatric Cardiac Anesthesiology Program Director’s Group (PCAPD) Committee
      • Communications Committee
      • CCAS-STS Database Committee
      • Education Committee
      • Global Health Committee
      • Membership Committee
      • Quality and Safety Committee
      • Research Committee
    • CCAS Special Interest Groups
      • Adult Congenital Heart Disease Special Interest Group (SIG)
      • ERAS Special Interest Group (SIG)
      • Hemostasis Special Interest Group (SIG)
      • Latin America Special Interest Group (SIG)
      • Pulmonary Hypertension Special Interest Group (SIG)
      • Trainee Special Interest Group (SIG)
  • Membership
    • Benefits of Membership
    • CCAS Member App
    • Membership Categories
    • Join CCAS
      • Online Application
      • Printable Application
    • Renew Your Dues
    • Sponsor a Member
    • Get Involved
  • Meetings
    • Upcoming Meetings
    • Past Meetings
    • Other Meetings
    • Exhibit Information
  • Education
    • CCAS Virtual Visiting Professor Program
    • CCAS Webinar Series
      • CCAS Webinar Series – Recordings
    • CCAS COVID 19 Webinar
    • ACHD-SIG Anesthesia Rounds
    • Lecture Series
    • Echo Tutorial
    • Archived Questions
    • Poll of the Month Archives
    • Review Articles
      • CCAS-CHiP Network Journal Watch Collaboration
      • SCVA Articles
    • Journals of Interest
    • Books of Interest
    • Educational Links
  • Resources
    • CCAS Position Statements
    • CCAS Committee Resources
    • CCAS Special Interest Group (SIG) Resources
    • CCAS Cognitive Aids
    • Newsletters
    • Research Resources
    • Mission Trips
    • Societies
    • Job Opportunities
  • Research
    • Research Committee
    • CCAS 2025 Meeting Scholarship for Students and Residents
    • Research Network & Collaborative Opportunities
    • Research Resources
    • Dolly D. Hansen, MD Research Award
    • Podcast Series for Aspiring CCAS Researchers
    • Highlight on a CCAS Researcher
    • Call for Surveys
    • STS-CCAS Database
    • Donate to the Dolly Hansen Fund
    • Grant Opportunities
  • Trainees
    • Introduction to Pediatric Cardiac Anesthesiology
    • Trainee Lecture Series
    • Advanced Training
    • Pediatric Cardiac Anesthesiology Fellowship Common Goals and Objectives
    • Frequently Asked Questions
    • Pediatric Cardiac Anesthesia Education Resources
    • Coaching/Mentoring Initiative
  • Patients
    • FAQs for Cardiac Anesthesia
    • FAQs for Cardiac Anesthesia – Spanish
    • SmartTots FAQs for Parents
    • Useful Resources for Parents

QOW 483

Author: Nicholas Houska, DO - University of Colorado, Children’s Hospital Colorado


A newborn boy with a prenatal diagnosis of Tetralogy of Fallot develops respiratory distress shortly after birth, subsequently requiring intubation and extracorporeal membrane oxygenation. A portable computed tomography scan of the chest demonstrates severe main pulmonary artery dilation and bronchial compression. Which of the following types of Tetralogy of Fallot is the MOST likely diagnosis in this neonate?

Correct! Wrong!

EXPLANATION


Tetralogy of Fallot (TOF) with absent pulmonary valve (TOF/APV) is a rare type of TOF (3%) associated with high fetal and neonatal morbidity and mortality. In this defect, severe pulmonary insufficiency due to the lack of pulmonary valve cusps leads to massive main and proximal pulmonary artery dilation and thus extrinsic airway compression. Volume and pressure overload of the right ventricle (RV) can lead to dysfunction, and tricuspid regurgitation with associated left ventricular dysfunction. Chromosomal anomalies are found in 46% of TOF/APV patients who undergo genetic testing, with 35% having the 22q11.2 deletion. The clinical presentation of TOF/APV lies on a spectrum, ranging from fetal hydrops or severe postnatal respiratory distress to mild cardiopulmonary symptoms during infancy. The necessity for postnatal respiratory or cardiovascular support is common, and many patients do not survive to surgical repair.


Given the increased utilization and diagnostic capabilities of fetal imaging and the poor prognosis of TOF/APV, pregnancy termination is common after prenatal diagnosis. A 2021 study found that in patients with intention to treat after birth, 9% died in utero and 27% died postnatally. Right ventricular dysfunction independently predicted overall mortality, while pulmonary artery z-scores did NOT correlate with outcomes. Management of TOF/APV includes respiratory support based on symptoms. Patients with mild obstructive symptoms may be supported with medical management, oxygen therapy, or non-invasive positive pressure ventilation until surgical repair. These patients are often prone to frequent respiratory infections, which may require hospitalization. Conversely, patients born with more severe respiratory distress may require prone positioning to alleviate compression and/or intubation and mechanical ventilation. Patients with the most severe respiratory failure or cardiovascular dysfunction may require extracorporeal membrane oxygenation and early surgical repair. Surgical repair includes addressing the ventricular septal defect, the right ventricular outflow tract with a valved or non-valved conduit, and pulmonary arterioplasty. There have also been case reports of combining cardiac repair of TOF/APV with external bronchial stenting to relieve airway compression.


Tetralogy of Fallot with Pulmonary Stenosis and Tetralogy of Fallot with Pulmonary Atresia are associated with normal, small, or discontinuous main and/or branch pulmonary arteries. The patient in the stem has a presentation most consistent with TOF/APV.


REFERENCES


Nuri H, Virgone A. Tetralogy of Fallot and absent pulmonary valve syndrome. Multimed Man Cardiothorac Surg. 2022 Nov 8;2022. doi: 10.1510/mmcts.2022.071


Pinsky WW, Nihill MR, Mullins CE, Harrison G, McNamara DG. The absent pulmonary valve syndrome. Considerations of management. Circulation. 1978;57(1):159-162. doi: 10.1161/01.cir.57.1.159. PMID: 618384.


Chelliah A, Moon-Grady AJ, Peyvandi S, et al. Contemporary outcomes in Tetralogy of Fallot with absent pulmonary valve after fetal diagnosis. J Am Heart Assoc. 2021;10(12):e019713.


Sakamoto T, Nagase Y, Hasegawa H, Shin'oka T, Tomimatsu H, Kurosawa H. One-stage intracardiac repair in combination with external stenting of the trachea and right bronchus for tetralogy of Fallot with an absent pulmonary valve and tracheobronchomalacia. J Thorac Cardiovasc Surg. 2005;130(6):1717-1718.


Poll of the Month

May 2025
At your institution, do you routinely send a TEG/ROTEM during the rewarming phase of cardiopulmonary bypass?
View Results
Total Answers 65
Total Votes 65

Upcoming Meeting Information


CCAS 2026 Annual Meeting

March 12, 2026
Sheraton Denver Downtown
Denver, CO

 

 

 

 

Join CCAS
Renew
Donate
Get Involved
Upcoming
Job Postings
  • Member Login
  • Forgot Password?
2209 Dickens Road, Richmond, VA 23230 • 804-282-9780 • [email protected]
Copyright © 2025 The Congenital Cardiac Anesthesia Society | View Privacy Policy